-
50 votes
-
Gilead shot prevents all HIV cases in trial of African women
29 votes -
mRNA cancer vaccine reprograms immune system to tackle glioblastoma
12 votes -
German man deliberately receives 217 Covid vaccinations over twenty-nine months, with no adverse events or strong effect on immune system
45 votes -
Progress deferred: Lessons from mRNA vaccine development
9 votes -
World's first "self-amplifying" vaccine approved in Japan
15 votes -
New vaccine technology could protect from future viruses and variants
The vaccine antigen technology, developed by the University of Cambridge and spin-out DIOSynVax in early 2020, provided protection against all known variants of SARS-CoV-2 – the virus that causes...
The vaccine antigen technology, developed by the University of Cambridge and spin-out DIOSynVax in early 2020, provided protection against all known variants of SARS-CoV-2 – the virus that causes COVID-19 – as well as other major coronaviruses, including those that caused the first SARS epidemic in 2002.
The studies in mice, rabbits and guinea pigs [...] found that the vaccine candidate provided a strong immune response against a range of coronaviruses by targeting the parts of the virus that are required for replication.
Professor Jonathan Heeney from Cambridge’s Department of Veterinary Medicine, who led the research, [said] “We wanted to come up with a vaccine that wouldn’t only protect against SARS-CoV-2, but all its relatives.”
18 votes -
Golden age of medicine
18 votes -
MIT’s vaccine printer: The game-changer in vaccine distribution
3 votes -
Moderna begins HIV vaccine trials
32 votes -
mRNA vaccine technology has helped repair broken hearts in mice
12 votes -
Vaccinia
6 votes -
Solving puzzles to create better COVID vaccines
2 votes -
What is in the COVID-19 vaccine?
4 votes -
The last time a vaccine saved America
7 votes -
First clinical trial confirms HIV vaccine using Moderna inoculation
22 votes -
Stabilizing RNA molecules to strengthen vaccines - including for COVID-19
6 votes -
How mRNA technology could change the world
8 votes -
How our brutal science system almost cost us a pioneer of mRNA vaccines
8 votes -
Team behind Oxford Covid jab start final stage of malaria vaccine trials
7 votes -
Wanted: Online gamers to help build a more stable Covid-19 vaccine
12 votes -
Smallpox and the long road to eradication
6 votes -
Ten years after vaccination was introduced, no HPV16/18 infections were found in sexually active 16-18 year old females in England according to public health data
15 votes -
Slaying the speckled monster - The history of smallpox and the origins of vaccines
6 votes -
A vaccine for cat allergies is in development; early results are promising, aiming for market release in 2022
7 votes -
Long-term measles vaccine study shows no link with autism — again
19 votes -
How the CIA’s fake vaccination campaign endangers us all
11 votes -
Anti-vaxxers are targeting a vaccine for a virus deadlier than ebola
7 votes -
Scientists hopeful as HIV vaccine candidate passes key test
Here's a news article about an HIV vaccine being tested on humans "in the field": Scientists hopeful as HIV vaccine candidate passes key test Here's the scientific report: Evaluation of a mosaic...
Here's a news article about an HIV vaccine being tested on humans "in the field": Scientists hopeful as HIV vaccine candidate passes key test
Here's the scientific report: Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)
13 votes -
HIV vaccine to begin human trials in 2019
16 votes -
Riding the tiger: or, flirting with the antivaxxers
5 votes